Navigation Links
JAAOS Study Exposes Importance of Child Safety Seats for Children between Four and Eight – Kiley Law Group, LLC
Date:6/24/2013

Andover, Massachusetts (PRWEB) June 24, 2013

According to a recent medical study released by the Journal of the American Academy of Orthopaedic Surgeons (June 18, 2013), child safety restraint systems have been found to be increasingly effective at preventing serious injury and deaths amongst children between the ages of four to eight years old. Tom Kiley Sr., Massachusetts personal injury lawyer, comments on the increasing role that child restraint systems have as more injury studies continue to be released.

According to the study, children deaths between the ages of one and three years old have fallen by more than 50% in the past three decades, but motor-vehicle collisions are still the leading cause of death amongst those between the ages of one and seventeen. The study found child safety restraint systems, such as booster seats, to significantly decrease the mortality rate when properly utilized.

Rather than creating programs directed towards decreasing costs for financially struggling parents, the doctors involved in the study suggested increasing awareness campaigns to highlight the life-saving potential of restraint systems for growing kids.
Tom Kiley Sr., Massachusetts Car Accident Lawyer, has assisted several people who have been involved in collisions that injured themselves and their families. “Having worked with several families that have suffered injuries from motor-vehicle collisions I believe the general public is aware of the importance of car seats. What is particularly interesting about this study are the age groups for which car and booster seats were found to be effective. As more studies continue to focus on children between four and eight years old, evidence continues to develop that supports booster seats for children up- to four feet nine inches tall. I highly doubt that the majority of Americans are placing their seven or eight year old in a booster seat in the back of their vehicles, but these studies recommend it.

“We have seen first-hand how the improper use of seat belts and car seats can lead to serious injury or death. These studies are the first step towards a better-informed public and safer kids. If putting our children in a booster seat until they are eight will greatly increase their chance of survival in a car accident, parents need to know. Hopefully we will continue to see the evidence develop and the information spread,” said A
ttorney Kiley.

About Kiley Law Group, LLC

Tom Kiley Senior is senior partner of Kiley Law Group, LLC. For over thirty years, Kiley Law Group, LLC has provided Massachusetts injury victims with personal injury assistance designed to help get people’s lives back on track. If you have suffered an injury in a car collision, motorcycle accident, truck collision, or any other type of motor-vehicle accident, speaking with an experienced lawyer may be in your best interest.

To speak with a Kiley Law Group representative call 888-208-1695 or visit Tom Kiley’s website for more information.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10862614.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. JAAOS study highlights success of nerve transfer surgery
2. Study Suggests Vaccine May Help Kids With Brain Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
5. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
6. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
7. No Added Cancer Risk From Hip Replacement Materials: Study
8. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
9. Early Study Finds Some Promise for Lung Cancer Vaccine
10. Narcissists Often Ace Job Interviews, Study Finds
11. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: